Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.10
Bid: 3.00
Ask: 3.20
Change: -0.10 (-3.13%)
Spread: 0.20 (6.667%)
Open: 3.10
High: 3.20
Low: 2.70
Prev. Close: 3.20
CHLL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Tobacco-Free Nicotine Product Line

23 Sep 2021 07:00

RNS Number : 6831M
Chill Brands Group PLC
23 September 2021
 

 

Chill Brands Group plc

('Chill', the 'Company' or the 'Group')

 

Launch of Tobacco-Free Nicotine Product Line

 

Chill Brands Group plc (LON:CHLL) (OTCQX:ZOEIF), the international CBD group, is pleased to announce the launch of an innovative new range of Tobacco-Free Nicotine ("TFN®") flavour pouches.

 

Highlights

 

● Chill joins short list of brands licensed to use TFN® from market leader, Next Generation Labs

 

● New product line exposes Chill to major growth opportunities in the worldwide flavour pouch market that is expected to reach US$32 billion by 2026

 

● The Company is among the first to use adult lifestyle marketing in the emerging tobacco-free nicotine product category through partnerships with renowned rodeo athletes

 

● Tobacco-free nicotine flavour pouches set to launch in retail outlets across the US and online via Chill.com in Q4 2021

 

The Group has developed a new line of tobacco-free nicotine flavour pouches that is set to launch in the coming months. These innovative new products have been created

using Next Generation Labs TFN® - a unique, market-leading nicotine product that is not derived from tobacco.

 

The Company's use of Next Generation Labs TFN® complements its existing lineup of CBD products which remain an anchor for its growth strategy. The global nicotine pouches market is projected to grow to US$32 billion by 2026. This launch is intended to pave the way for Chill to become a market leader through the sale of desirable CBD and TFN® nicotine alternatives.

 

Chill's new product line will be distributed through the Company's extensive network of retail partners and is positioned to benefit from shifting consumer sentiment. Recent months have seen some of the world's foremost tobacco companies set out plans for the gradual discontinuation of traditional tobacco products which may signal their ultimate social stigmatisation and decline. The Group is now well placed to capitalise on this underlying shift in consumer sentiment through its CBD and TFN® lines.

 

Highly significant marketing and promotional initiatives are now underway to support the expansion of the Chill tobacco-alternative product line. The Company is represented by a number of professional rodeo athletes who regularly appear in the media and are highly regarded by the rodeo community - a historical mainstay of the traditional chewing tobacco market. The Company is committed to underpinning its novel lifestyle marketing strategy by forming key partnerships in other sporting communities and looks forward to updating the market in due course. 

 

Chill Tobacco-Free Nicotine Flavour Pouches will be available online at Chill.com and at retail points of sale across the United States from Q4 2021.

 

Antonio Russo, Co-CEO of Chill Brands Group, said: "We are excited to be working with Next Generation Labs and are pleased to have secured use of its groundbreaking TFN® nicotine which will greatly improve our ability to compete with traditional tobacco and vape products while complementing our current tobacco alternative line of products. Our existing manufacturing, distribution, and sales capabilities have enabled Chill to make a rapid entrance to this market and we are confident that we will gain a running start in this multi-billion-dollar emerging product category."

 

About Chill Tobacco-Free Nicotine Flavour Pouches

 

Chill Tobacco-Free Nicotine Flavour Pouches are an alternative to the traditional smokeless tobacco products used by almost 5.9 million Americans and millions of others worldwide. Available in appetizing flavours including mint, mango, and lemon, the flavour pouches contain TFN® (tobacco-free nicotine) manufactured by Next Generation Labs. Users of the TFN® flavour pouches can expect familiar textures and the freedom to choose products that do not contain tobacco-derived nicotine. 

 

About TFN®

 

TFN® is a tobacco-free nicotine product exclusively manufactured by Next Generation Labs. TFN® nicotine is not derived from tobacco leaf, stem, reconstituted sheet, or expanded or post-production waste dust. The nicotine is made using a patented manufacturing process that begins with a natural starter material, and progressively builds around the molecules of that material to create a pure synthetic nicotine. TFN® is virtually tasteless and odourless, and is devoid of all tobacco-derived residual impurities.

 

More information about TFN® can be found at https://www.nextgenerationlabs.com.

 

-ENDS-

 

Media enquiries:

 

Chill Brands Group plc

 

c/o Buchanan

Trevor Taylor, Co-CEO

Antonio Russo, Co-CEO

 

 

 

Allenby Capital Limited (Financial Adviser and Broker)

 

+44 (0) 20 3328 5656

Nick Harriss / Nick Naylor (Corporate Finance)

 

 

Kelly Gardiner (Equity Sales)

 

 

 

Buchanan

 

 

Henry Harrison-Topham / Jamie Hooper / Ariadna Peretz

 

Tel: +44 (0) 20 7466 5000

chillbrands@buchanan.uk.com

 

www.buchanan.uk.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEDFUEEFSESU
Date   Source Headline
17th Apr 20243:18 pmRNSReceipt of Requisition Letter
16th Apr 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSInvestor Presentation via Investor Meet Company
31st Jan 20245:00 pmRNSTotal Voting Rights
29th Jan 20247:00 amRNSResponse to Government Proposals
26th Jan 20247:00 amRNSEquity Fundraising
3rd Jan 20247:00 amRNSProduct Strategy Update
29th Dec 202312:30 pmRNSTotal Voting Rights
28th Dec 20237:00 amRNSHalf-year Report for the 6 months to 30 Sep 2023
22nd Dec 20237:00 amRNSProduct Sale to Leading Forecourt Operator
20th Dec 20237:00 amRNSVape Sale into Major Retailer
7th Dec 20237:00 amRNSTrading Statement
30th Nov 20231:15 pmRNSPublication of a Prospectus
17th Nov 20237:00 amRNSSale of Vapes to Leading UK Distributor
9th Nov 20237:00 amRNSProducts to Launch on Leading UK Wholesale Website
12th Oct 20237:00 amRNSProduct Launch on Amazon
9th Oct 20237:00 amRNSVape Sale to Major Retailer
19th Sep 20236:00 pmRNSResult of AGM
19th Sep 20237:00 amRNSAGM Statement
11th Sep 20237:00 amRNSProvisional Grant of Share Options
7th Sep 20237:00 amRNSTrading Update
24th Aug 20237:00 amRNSNotice of AGM
28th Jul 20231:00 pmRNSFinal Results for the year to 31 March 2023
21st Jun 20237:00 amRNSUpdate on Chill.com Marketplace
5th Jun 20237:00 amRNSUpdate on Shipping of Vapour Products
31st May 20235:00 pmRNSTotal Voting Rights
18th May 20237:30 amRNSUK Sales and Distribution Partnership
15th May 20235:45 pmRNSHolding(s) in Company
15th May 202311:30 amRNSHolding(s) in Company
15th May 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSCompany Raises £2.6 million
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSLaunch of Vapour Products
16th Mar 20232:45 pmRNSCompany Raises £560,000
14th Mar 20239:30 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSCommencement of Third-Party Sales
28th Dec 202212:00 pmRNSHalf-year Report for the period to 30 Sept. 2022
12th Dec 20227:00 amRNSExpansion of Retail Programme
7th Dec 20227:00 amRNSPlanned Launch of Vape Products
31st Oct 20225:04 pmRNSResult of Adjourned AGM
31st Oct 20227:00 amRNSTrading Statement ahead of AGM
19th Oct 202211:53 amEQSChill Brands kicks off 'new era' with website relaunch
18th Oct 20227:00 amRNSConsumer Website Launch
12th Oct 20228:00 amRNSLaunch of Dispensary Sales Pilot Programme
30th Sep 20227:45 amRNSFinal Results for the year to 31 March 2022
29th Sep 20224:30 pmRNSResult of AGM
29th Sep 20221:00 pmRNSAGM Statement
23rd Sep 20228:00 amRNSUK Marketing Partnership
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.